Open·Ingested 90 days ago, not re-verified since

DoW Alzheimer’s Transforming Diagnosis Award

Defense Health Agency Contracting Activity - DHACA

Go to the official application

Free. Verify your email, then we send one reminder only.

Download details (file)

Posted: May 1, 2026
Amount: $3,200,000
Closes: Sep 24, 2026 (in 55 days)

Similar opportunities open now

DoW Alzheimer’s Transforming Care AwardOpenDefense Health Agency Contracting Activity - DHACACloses in 55 days
DoW Alzheimer’s Transforming Research AwardOpenDefense Health Agency Contracting Activity - DHACACloses in 55 days
DoW Traumatic Brain Injury and Psychological Health, Translational Research AwardOpenDefense Health Agency Contracting Activity - DHACACloses in 76 days
DoW Duchenne Muscular Dystrophy, Clinical/Translational Research AwardOpenDefense Health Agency Contracting Activity - DHACACloses in 49 days
DoW Traumatic Brain Injury and Psychological Health, Clinical Trial AwardOpenDefense Health Agency Contracting Activity - DHACACloses in 76 days

Classification and identifiers

Solicitation number: HT942526AZRPTRDA
Assistance listing (CFDA): 12.420

Amount

$3,200,000

Who can apply

Open to all

About this opportunity

Summary: The fiscal year 2026 (FY26) Alzheimer’s Research Program (AZRP) Transforming Diagnosis Award (TrDA) supports non-incremental, solutions-oriented research that reduces or overcomes important barriers to obtaining a diagnosis, meaningful disease monitoring and accurate prognosis. Distinctive Features: Clinical research is allowed, however clinical trials and animal research are prohibited. Preliminary data are required. Community collaboration is required for studies prospectively enrolling human subjects. Study Population: The AZRP encourages studies to leverage existing cohorts/datasets. Cohorts consisting of individuals 65 years or younger are also encouraged. Career Initiation or Transition (CIT) Partnership Option: The TrDA includes an option for more than one PI and supports b...